Michael A. DesJardin - 21 Jan 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role: EVP, Technical Operations
Signature: /s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 21 Jan 2022
Net transactions value: -$157,716
Form type: 4
Filing time: 24 Jan 2022, 16:07:37 UTC
Previous filing: 06 Jan 2022
Next filing: 04 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HZNP	Ordinary Shares	Options Exercise	$0	+3,679	+2.7%	$0.000000	139,385	21 Jan 2022	Direct
transaction	HZNP	Ordinary Shares	Tax liability	$157,716	-1,825	-1.3%	$86.42	137,560	21 Jan 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HZNP	Restricted Stock Units (RSUs)	Options Exercise	$0	-3,679	-100%	$0.000000^*	0	21 Jan 2022	Ordinary Shares	3,679		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each RSU represents a contingent right to receive one ordinary share of the Issuer.